Since 2016, the Science Fund’s
grant financing of high-tech projects has generated over 35 billion tenge in
income from product sales, with exports amounting to 560 million tenge. During
this period, the fund held five competitions, receiving more than 1,700
applications. Out of these, 175 productions have successfully entered the
market, 16 have expanded to foreign markets, and five have achieved sales
exceeding one billion tenge.
«We support an average of 60 to
70 projects annually, with plans to assist 75 projects this year. Currently, we
are in the evaluation stage of the sixth commercialization competition. Out of
over 300 applications received, 70 projects have been approved for funding
until 2027. They are predominantly focused on sectors such as agriculture,
subsoil use, namely metallurgy and mining, as well as healthcare,» said Renat
Yelshibekov, Head of the Committee of Science at the Kazakh Ministry of Science
and Higher Education.
The technology commercialization
reactor helps promote the innovations of Kazakh scientists, offering them a
unique opportunity to find business partners. At the latest event on
integrating science and business, dozens of unique developments in the medical
and pharmaceutical industries were showcased. Notably, these projects primarily
come from practicing domestic doctors with extensive experience, such as
Meyirbek Aimagambetov and other scientists from Semey Medical University, who developed
universal retractors.
«We have showcased our
achievements of 20 years of practical and scientific work at the exhibition.
Our presentation features a tool called the universal retractor, designed to
facilitate surgical procedures by expanding wounds, retracting organs, and
creating comfortable surgical conditions. We are displaying three types of
retractors, including for small, medium, and large incisions, along with
additional instruments. Our next step involves manufacturing the tool to apply
in surgical departments in the production form,» said Aimagambetov.
As a result of the latest
technology commercialization reactor, several scientists have already reached
preliminary agreements with businesses to jointly implement high-tech
production projects.